Clinical Trial Update: Cognitive Remediation With D-Cycloserine [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating cognitive remediation with D-Cycloserine for smoking cessation has completed and results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking Cessation

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Smoking Cessation | Phase 3 | Status: COMPLETED | Results posted: 2015-05-04